Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vixxol is a South Korean biotechnology company specializing in the development and manufacture of high-purity phospholipids and functional food ingredients. The company is a leading producer of Phosphatidylserine (PS), a nutrient known for supporting cognitive health and brain function, derived from soy or sunflower lecithin. Vixxol utilizes proprietary enzymatic conversion technologies to produce high-quality ingredients for the global nutraceutical and pharmaceutical industries. Their product portfolio also includes Phosphatidic Acid (PA) and other specialty lipids used in dietary supplements and functional foods. The company maintains a strong focus on R&D to expand the applications of phospholipids in health and wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vixxol.